Refractory multisystem Langerhans cell histiocytosis in an infant: use of vemurafenib as a therapeutic option

Author unknown

Open source

DOI
10.5546/aap.2025-10774.eng
Published
2026-04-01
Container
Archivos Argentinos de Pediatria
Publisher
Sociedad Argentina de Pediatria
Open access
unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5546/aap.2025-10774.eng,
  title = {Refractory multisystem Langerhans cell histiocytosis in an infant: use of vemurafenib as a therapeutic option},
  year = {2026},
  journal = {Archivos Argentinos de Pediatria},
  doi = {10.5546/aap.2025-10774.eng},
  url = {https://doi.org/10.5546/aap.2025-10774.eng}
}

RIS

TY  - JOUR
TI  - Refractory multisystem Langerhans cell histiocytosis in an infant: use of vemurafenib as a therapeutic option
PY  - 2026
JO  - Archivos Argentinos de Pediatria
DO  - 10.5546/aap.2025-10774.eng
UR  - https://doi.org/10.5546/aap.2025-10774.eng
ER  - 

APA

Refractory multisystem Langerhans cell histiocytosis in an infant: use of vemurafenib as a therapeutic option. (2026). Archivos Argentinos de Pediatria. https://doi.org/10.5546/aap.2025-10774.eng

Source records